Copyright
©The Author(s) 2022.
World J Clin Cases. May 16, 2022; 10(14): 4425-4435
Published online May 16, 2022. doi: 10.12998/wjcc.v10.i14.4425
Published online May 16, 2022. doi: 10.12998/wjcc.v10.i14.4425
Table 3 Comparison of therapeutic efficacy according to western medical evaluation indexes
| Variates | Non-PND group(n = 31) | PND group(n = 29) | P value |
| Neutrophil engraftment time | 0.454 | ||
| Median | 12 | 12 | |
| Range | 10–15 | 10–14 | |
| Platelet engraftment time | 0.039 | ||
| Median | 13 | 12 | |
| Range | 9–145 | 8–152 | |
| RBC transfusion frequency | 0.033 | ||
| Median | 1 | 0 | |
| Range | 0–22 | 0–3 | |
| Platelet transfusion frequency | 0.035 | ||
| Median | 3 | 2 | |
| Range | 1–46 | 1–49 | |
| Poor graft function, n (%) | 8 (25.8) | 1 (3.4) | 0.027 |
| Infections within 100 d, n (%) | 27 (87.1) | 23 (79.3) | 0.500 |
| Cytomegaloviremia | 15 (48.4) | 11 (37.9) | |
| Pneumonia | 7 (22.6) | 7 (24.1) | |
| Sepsis | 2 (6.5) | 3 (10.3) | |
| Other infections | 3 (9.7) | 2 (6.9) | |
| aGVHD, n (%) | 14 (45.2) | 17 (58.6) | 0.316 |
| Ⅰ-Ⅱ | 11 (35.5) | 14 (48.3) | |
| Ⅲ-Ⅳ | 3 (9.7) | 3 (10.3) | |
| Relapse, n (%) | 9 (29.0) | 2 (6.9) | 0.043 |
- Citation: Yuan JJ, Lu Y, Cao JJ, Pei RZ, Gao RL. Hematopoiesis reconstitution and anti-tumor effectiveness of Pai-Neng-Da capsule in acute leukemia patients with haploidentical hematopoietic stem cell transplantation. World J Clin Cases 2022; 10(14): 4425-4435
- URL: https://www.wjgnet.com/2307-8960/full/v10/i14/4425.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i14.4425